Outset Medical (OM) Revenue (2019 - 2026)

Outset Medical (OM) has 8 years of Revenue data on file, last reported at $27.9 million in Q1 2026.

• On a quarterly basis, Revenue fell 6.35% year-over-year to $27.9 million in Q1 2026; TTM through Mar 2026 was $117.6 million, a 2.01% increase from a year earlier, with the FY2025 full-year figure at $119.5 million, up 5.09% from the prior year.
• Revenue for Q1 2026 stood at $27.9 million, down from $28.9 million in the prior quarter.
• Over the last five years, Revenue for OM reached as high as $36.0 million in Q2 2023 and fell as low as $25.1 million in Q2 2022.
• Historically, Revenue has averaged $29.8 million across 5 years, with a median of $29.5 million in 2024.
• Across the five-year window, Revenue jumped 43.83% in 2023 and declined 24.01% in 2024, its largest moves.
• Year by year, Revenue stood at $32.0 million in 2022, then retreated by 4.69% to $30.5 million in 2023, then slipped by 3.41% to $29.5 million in 2024, then declined by 2.01% to $28.9 million in 2025, then slipped by 3.5% to $27.9 million in 2026.
• Per Business Quant data, the three most recent Revenue figures were $27.9 million in Q1 2026, $28.9 million in Q4 2025, and $29.4 million in Q3 2025.